Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.

Breast cancer research and treatment - 1 Jul 2010

Yao Lei, Fang Fang, Wu Qi, Yang Zhen, Zhong Yang, Yu Long

Abstract excerpt

Breast cancer is one of the most common malignant tumors worldwide. To date, many articles have evaluated the association between Cytochrome P450c17 (CYP17) T-34C polymorphism and breast cancer risk. However, the results remain inconclusive. In order to derive a more precise estimation of the association, a meta-analysis was performed in this study. By searching Medline, ISI Web of Knowledge, Cochrane,...

Topics

5' Untranslated Regions
Breast Neoplasms
Case-Control Studies
Ethnicity
Female
Genetic Predisposition to Disease
Genotype
Humans
Menopause
Odds Ratio
Polymorphism, Restriction Fragment Length

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Risk

Steroid 17-alpha-Hydroxylase

Source

Identifiers

PMID: 20013047
DOI: 10.1007/s10549-009-0679-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.PMID 20013047Read ↗

Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.Semantic proximity Read ↗

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.Semantic proximity Read ↗

Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis.Semantic proximity Read ↗

The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.Semantic proximity Read ↗

Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.Semantic proximity Read ↗

Cytochrome P450 1A1 (CYP1A1) Gene Polymorphisms and Susceptibility to Breast Cancer: a Meta-Analysis in the Chinese Population.Semantic proximity Read ↗

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.Semantic proximity Read ↗

Association between CYP17 polymorphisms and the development of breast cancer.Semantic proximity Read ↗

Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer.Semantic proximity Read ↗

Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls.Semantic proximity Read ↗

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.